1. ScholarBank@NUS

Dario Campana

rp02332

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Dario Campana
Variants
Campana, Dario
Campana, D.
 
Main Affiliation
 
Faculty
 
Email
paedc@nus.edu.sg
 

Publications

Results 1-12 of 12 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
12015A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killingPrapa, M; Caldrer, S; Spano, C; Bestagno, M; Golinelli, G; Grisendi, G; Petrachi, T; Conte, P; Horwitz, E.M; Campana, D ; Paolucci, P; Dominici, M
22018A novel integrase-mediated seamless vector transgenesis platform for therapeutic protein expressionMakhija, H.; Roy, S.; Hoon, S.; Ghadessy, F.J.; Wong, D. ; Jaiswal, R.; Campana, D. ; Dr鰃e, P.
32010Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicityVoskens, C.J; Watanabe, R; Rollins, S; Campana, D ; Hasumi, K; Mann, D.L
4Oct-2012Large-scale ex vivo expansion and characterization of natural killer cells for clinical applicationsLapteva, N.; Durett, A.G.; Sun, J.; Rollins, L.A.; Huye, L.L.; Fang, J.; Dandekar, V.; Mei, Z.; Jackson, K.; Vera, J.; Ando, J.; Ngo, M.C.; Coustan-Smith, E. ; Campana, D. ; Szmania, S.; Garg, T.; Moreno-Bost, A.; Vanrhee, F.; Gee, A.P.; Rooney, C.M.
57-Mar-2013Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signalingZhang, B.; Li, M.; McDonald, T.; Holyoake, T.L.; Moon, R.T.; Campana, D. ; Shultz, L.; Bhatia, R.
6Dec-2011Natural killer cell engineering for cellular therapy of cancerShook, D.R.; Campana, D. 
730-Jan-2022Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinomaLim, Chwee Ming ; Liou, Anthony ; Poon, Michelle ; Koh, Liang Piu ; Tan, Lip Kun ; Loh, Kwok Seng ; Petersson, Bengt Fredrik ; Ting, Eric ; Campana, Dario ; Goh, Boon Cher ; Shimasaki, Noriko 
82015Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapyKarol, Seth E.; Coustan-Smith, Elaine ; Cao, Xueyuan; Shurtleff, Sheila A.; Raimondi, Susana C.; Choi, John K.; Ribeiro, Raul Corr�a; Dahl, Gary V.; Bowman, William Paul; Taub, Jeffrey Warren; Degar, Barbara A.; Leung, Wing; Downing, James R.; Pui, Chinghon; Rubnitz, Jeffrey E.; Campana, Dario ; Inaba, Hiroto
92011Pronounced hypoxia in models of murine and human leukemia: High efficacy of hypoxia-activated prodrug PR-104Benito J.; Shi Y.; Szymanska B.; Carol H.; Boehm I.; Lu H.; Konoplev S.; Fang W.; Zweidler-McKay P.A.; Campana D. ; Borthakur G.; Bueso-Ramos C.; Shpall E.; Thomas D.A.; Jordan C.T.; Kantarjian H.; Wilson W.R.; Lock R.; Andreeff M.; Konopleva M.
10Sep-2013RRM1 and RRM2 pharmacogenetics: Association with phenotypes in HapMap cell lines and acute myeloid leukemia patientsCao, X.; Mitra, A.K.; Pounds, S.; Crews, K.R.; Gandhi, V.; Plunkett, W.; Dolan, M.E.; Hartford, C.; Raimondi, S.; Campana, D. ; Downing, J.; Rubnitz, J.E.; Ribeiro, R.C.; Lamba, J.K.
112017The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemiaEissa, H.M; Zhou, Y; Panetta, J.C; Browne, E.K; Jeha, S; Cheng, C; Relling, M.V; Campana, D ; Pui, C.-H; Inaba, H
12Nov-2012The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: A children's oncology group reportPatel, J.L.; Smith, L.M.; Anderson, J.; Abromowitch, M.; Campana, D. ; Jacobsen, J.; Lones, M.A.; Gross, T.G.; Cairo, M.S.; Perkins, S.L.